Oncology & Cancer

OnabotulinumtoxinA effect lasts in overactive bladder

(HealthDay)—OnabotulinumtoxinA treatment is safe and effective for long-term treatment of overactive bladder syndrome, according to a study published in the September issue of The Journal of Urology.

Obstetrics & gynaecology

New thesis identifies risks for urinary incontinence due to fistula

Four per cent of women between the ages of 15 and 49 in western Uganda live with urinary and/or faecal incontinence caused by genital fistulas. In a new doctoral thesis, Justus Barageine identifies the risk factors in this ...

page 9 from 20